A current editor and former editor of the New England Journal of Medicine, which last month criticized drug maker Merck & Co. for withholding data from a published study on its withdrawn painkiller Vioxx, will be grilled next week by the company’s lawyers.
Spurred by the Vioxx fiasco, CEO Clark is trying to revamp the drug giant's culture
FDA Will Start Issuing Drug Safety Reports
By Andrew Bridges The public outcry over the withdrawal of the painkiller Vioxx is leading to closer government scrutiny of new drugs to identify and disclose late-developing safety problems.
Pretrial Arguments Heard in Vioxx Trial
Lawyers preparing for the nation's first state Vioxx-related wrongful death lawsuit to go to trial argued Thursday over what expert testimony jurors would hear.
Contact:
Copyright © 2005 Vioxx Advisor.com All Rights Reserved